Increased MMP-9 and TIMP-1 in mouse neonatal brain and plasma and in human neonatal plasma after hypoxia-ischemia: A potential marker of neonatal encephalopathy

Pediatric Research

Volumn 71, Issue 1, 2012, Pages 63-70

  Bednarek, Nathalie ^a,b,c,d   Svedin, Pernilla ^e   Garnotel, Roselyne ^f   Favrais, Géraldine ^a,b,c   Loron, Gauthier ^a,b,c,d   Schwendiman, Leslie ^a,b,c   Hagberg, Henrik ^g   Morville, Patrice ^d   Mallard, Carina ^e   Gressens, Pierre ^a,b,c,g  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PremUP   (France)

^d Alix de Champagne   (France)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; IBOTENIC ACID; LIPOPOLYSACCHARIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; MEASUREMENT; MOUSE; NEONATAL ENCEPHALOPATHY; NEWBORN; NEWBORN DISEASE; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BRAIN; FEMALE; GESTATIONAL AGE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 83655197527     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2011.3     Document Type: Article

References (31)

1. Okereafor A, Allsop J, Counsell SJ, et al. Patterns of brain injury in neonates exposed to perinatal sentinel events. Pediatrics 2008;121:906-14.
2. Bodensteiner JB, Johnsen SD. Magnetic resonance imaging (MRI) findings in children surviving extremely premature delivery and extremely low birthweight with cerebral palsy. J Child Neurol 2006;21:743-7. (Pubitemid 44696721)
3. Dzwonek J, Rylski M, Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 2004;567:129-35. (Pubitemid 38686435)
4. Ranasinghe HS, Williams CE, Christophidis LJ, Mitchell MD, Fraser M, Scheepens A. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury. Neuroscience 2009;158:732-44.
5. Agrawal SM, Lau L, Yong VW. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 2008;19:42-51. (Pubitemid 350235982)
6. Wang X, Jung J, Asahi M, et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 2000;20:7037-42.
7. Svedin P, Hagberg H, Sävman K, Zhu C, Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007;27:1511-8. (Pubitemid 46280068)
8. Zhao BQ, Wang S, Kim HY, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006;12:441-5.
9. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005;50:329-39. (Pubitemid 40780839)
10. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J Neurosci 1997;17:4223-35. (Pubitemid 27220613)
11. Magnoni S, Baker A, Thomson S, et al. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and-2 in ischemic brain injury. Gene Ther 2007;14:621-5. (Pubitemid 46444536)
12. Tejima E, Guo S, Murata Y, et al. Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J Neurotrauma 2009;26:1935-41.
13. Docherty AJ, O'Connell J, Crabbe T, Angal S, Murphy G. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol 1992;10:200-7.
14. Montaner J, Alvarez-Sabín J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001;32:1759-66. (Pubitemid 32772204)
15. Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9: 131-41. (Pubitemid 11191192)
16. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995;54:358-70.
17. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001;13:1101-6. (Pubitemid 32275747)
18. Medja F, Lelièvre V, Fontaine RH, et al. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice. Brain 2006;129(Pt 12):3209-23. (Pubitemid 44871437)
19. Bednarek N, Clément Y, Lelièvre V, et al. Ontogeny of MMPs and TIMPs in the murine neocortex. Pediatr Res 2009;65:296-300.
20. Volpe JJ. Neurology of the Newborn. Philadelphia, PA: Saunders, 2008:401-80.
21. Chen W, Hartman R, Ayer R, et al. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J Neurochem 2009;111:726-36.
22. Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, Uney JB. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 2003;22:98-106. (Pubitemid 36269119)
23. Worthmann H, Tryc AB, Goldbecker A, et al. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc Dis 2010;30:85-92.
24. Hasegawa K, Ichiyama T, Isumi H, Nakata M, Sase M, Furukawa S. NFkappaB activation in peripheral blood mononuclear cells in neonatal asphyxia. Clin Exp Immunol 2003;132:261-4. (Pubitemid 36560621)
25. Tong W, Chen W, Ostrowski RP, et al. Maternal hypoxia increases the activity of MMPs and decreases the expression of TIMPs in the brain of neonatal rats. Dev Neurobiol 2010;70:182-94.
26. Dragun P, Makarewicz D, Wójcik L, Ziemka-Nalecz M, Slomka M, Zalewska T. Matrix metaloproteinases activity during the evolution of hypoxic-ischemic brain damage in the immature rat. The effect of 1-methylnicotinamide (MNA). J Physiol Pharmacol 2008;59:441-55.
27. Lorek A, Takey Y, Cady EB, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the new born piglet: continuous 48 hours studies by phosphorus magnetic resonance spectroscopy. Ped Res 1994;36:699-706. (Pubitemid 24357779)
28. Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003;107:598-603. (Pubitemid 36176811)
29. Lorenzl S, De Pasquale G, Segal AZ, Beal MF. Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia. Stroke 2003;34:e37-8; author reply e37-8.
30. Sunagawa S, Ichiyama T, Honda R, Fukunaga S, Maeba S, Furukawa S. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia. Brain Dev 2009;31:588-93.
31. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976;33: 696-705.